Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions

被引:58
作者
Du, Jing [1 ]
Li, Feng-Hua [1 ]
Fang, Hua [1 ]
Xia, Jian-Guo [1 ]
Zhu, Cai-Xia [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Ultrasound, Shanghai 200127, Peoples R China
关键词
breast lesion; contrast-enhanced ultrasonography; microvessel density; vascular endothelial growth factor;
D O I
10.7863/jum.2008.27.6.821
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective. The purpose of this study was to determine the correlation of real-time gray scale contrast-enhanced ultrasonographic (CEUS) patterns and parameters with microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression for assessment of angiogenesis in breast lesions. Methods. Real-time gray scale CEUS was performed in 53 women with breast lesions. Contrast-enhanced ultrasonographic patterns and quantitative parameters were analyzed. Mean MVD and VEGF expression in breast lesions were measured by immuno-histochemical analysis. Results. Surgical pathologic analysis showed 25 benign and 28 malignant lesions. Different CEUS patterns were observed in the high- and low-MVD and -VEGF groups. Microvessel density and VEGF expression were significantly associated with heterogeneous enhancement with or without perfusion defects and radial or penetrating vessels surrounding the lesions (P <.05). The enhancement order and degree were significantly related to MVD (P <.01) but not correlated with VEGF expression (P >.05). Malignant and benign lesions did not differ significantly in time-intensity parameters (P >.05). The peak intensity, rise in intensity, maximum rise slope of the curve, wash-out slope of the curve, and area under the time-intensity curve (area) were statistically correlated with MVD (P <.05). The highest correlation (r=0.56; P <.001), however, was between the area and MVD. No significant association was found between any CEUS parameters and VEGF expression (P >.05). Conclusions. Contrast-enhanced ultrasonographic patterns and parameters of breast lesions are more closely correlated with MVD than VEGF expression. Real-time gray scale CEUS has a potential role in evaluating angiogenesis in breast lesions, but CEUS parameters are not correlated with the malignancy or benignity of breast tumors.
引用
收藏
页码:821 / 831
页数:11
相关论文
共 25 条
[1]   Angiogenesis in invasive breast carcinoma - a prospective study of tumour heterogeneity [J].
Ahlgren, J ;
Risberg, B ;
Villman, K ;
Bergh, J .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (01) :64-69
[2]  
Bolat F, 2006, J EXP CLIN CANC RES, V25, P365
[3]  
Broillet A, 2005, Acad Radiol, V12 Suppl 1, pS28, DOI 10.1016/j.acra.2005.02.021
[4]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91
[5]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[6]   Ultrasound for the visualization and quantification of tumor microcirculation [J].
Foster, FS ;
Burns, PN ;
Simpson, DH ;
Wilson, SR ;
Christopher, DA ;
Goertz, DE .
CANCER AND METASTASIS REVIEWS, 2000, 19 (1-2) :131-138
[7]  
Gasparini G, 2000, Oncologist, V5 Suppl 1, P37
[8]   Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis [J].
Heimann, R ;
Ferguson, D ;
Gray, S ;
Hellman, S .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :147-158
[9]   BENIGN AND MALIGNANT BREAST-LESIONS - DIFFERENTIATION WITH ECHO-PLANAR MR-IMAGING [J].
HULKA, CA ;
SMITH, BL ;
SGROI, DC ;
TAN, LJ ;
EDMISTER, WB ;
SEMPLE, JP ;
CAMPBELL, T ;
KOPANS, DB ;
BRADY, TJ ;
WEISSKOFF, RM .
RADIOLOGY, 1995, 197 (01) :33-38
[10]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30